In search of neuroprotective therapies based on the mechanisms of estrogens

References

• Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog. Neurobiol.63, 29–60 (2001).
   PubMed Web of Science ®Google Scholar
• D’Souza DN, Zhang Y, Damjanoska KJ et al. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Gα(i/o/z) proteins in the hypothalamus of ovariectomized rats. Neuroendocrinology80, 31–41 (2004).
   PubMed Web of Science ®Google Scholar
• Paradiso K, Zhang J, Steinbach JH. The C terminus of the human nicotinic α4β2 receptor forms a binding site required for potentiation by an estrogenic steroid. J. Neurosci.21, 6561–6568 (2001).
   PubMed Web of Science ®Google Scholar
• Nakazawa K, Ohno Y. Modulation by estrogens and xenoestrogens of recombinant human neuronal nicotinic receptors. Eur. J. Pharmacol.430, 175–183 (2001).
   PubMed Web of Science ®Google Scholar
• Wise PM. Estrogens: protective or risk factors in brain function? Prog. Neurobiol.69, 181–191 (2003).
   Google Scholar
• Yaffe K, Barnes D, Lindquist K et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol. Aging28, 171–178 (2007).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. Estrogen and cognitive aging in women. Neuroscience138, 1021–1026 (2006).
   PubMed Web of Science ®Google Scholar
• Lord C, Buss C, Lupien SJ, Pruessner JC. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol. Aging DOI 10.1016/j.neurobiolaging.2006.09.001 (2007) (Epub ahead of print).
   Google Scholar
• Shumaker SA, Legault C, Rapp SR et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA289, 2651–2662 (2003).
   PubMed Web of Science ®Google Scholar
• Ciriza I, Carrero P, Frye CA, Garcia-Segura LM. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol.66, 916–928 (2006).
   Google Scholar
• Nilsen J, Morales A, Brinton RD. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol. Endocrinol.22, 355–361 (2006).
   PubMed Web of Science ®Google Scholar
• Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology143, 205–212 (2002).
   PubMed Web of Science ®Google Scholar
• Espeland MA, Rapp SR, Shumaker SA et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: women’s health initiative memory study. JAMA291, 2959–2968 (2004).
   PubMed Web of Science ®Google Scholar
• Shumaker SA, Legault C, Kuller LH et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study, JAMA291, 2947–2958 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao L, Brinton RD. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer’s disease. BMC Neurosci.7, 24 (2006).
   Google Scholar
• Picazo O, Azcoitia I, Garcia-Segura LM. Neuroprotective and neurotoxic effects of estrogens. Brain Res.990, 20–27 (2003).
   PubMed Web of Science ®Google Scholar
• Maki PM. Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience138, 1027–1030 (2006).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J. Neuroendocrinol.19, 77–81 (2007).
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA285, 1489–1499 (2001).
   PubMed Web of Science ®Google Scholar
• Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA288, 2123–2129 (2002).
   PubMed Web of Science ®Google Scholar
• Zhao L, O’Neill K, Brinton RD. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res. Brain Res. Rev.49, 472–493 (2005).
   PubMedGoogle Scholar
• Dhandapani KM, Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod.67, 1379–1385 (2002).
   PubMed Web of Science ®Google Scholar
• Ciriza I, Carrero P, Azcoitia I, Lundeen SG, Garcia-Segura LM. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J. Neurobiol.61, 209–221 (2004).
   PubMedGoogle Scholar
• Azcoitia I, Moreno A, Carrero P, Palacios S, Garcia-Segura LM. Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecol. Endocrinol.22, 63–69 (2006).
   PubMed Web of Science ®Google Scholar
• Zhao L, O’Neill K, Brinton RD. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J. Pharmacol. Exp. Ther.319, 1124–1132 (2006).
   PubMed Web of Science ®Google Scholar
• Rossberg MI, Murphy SJ, Traystman RJ, Hurn PD. LY353381.HCl, a selective estrogen receptor modulator, and experimental stroke. Stroke31, 3041–3046 (2000).
   Google Scholar
• Callier S, Morissette M, Grandbois M, Pelaprat D, Di Paolo T. Neuroprotective properties of 17β-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse41, 131–138 (2001).
   PubMed Web of Science ®Google Scholar
• Mehta SH, Dhandapani KM, De Sevilla LM, Webb RC, Mahesh VB, Brann DW. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology77, 44–50 (2003).
   PubMed Web of Science ®Google Scholar
• Kimelberg HK, Jin Y, Charniga C, Feustel PJ. Neuroprotective activity of tamoxifen in permanent focal ischemia. J. Neurosurg.99, 138–142 (2003).
   Google Scholar
• Mickley KR, Dluzen DE. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice. Neuroendocrinology79, 305–316 (2004).
   Google Scholar
• Kokiko ON, Murashov AK, Hoane MR. Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury. Behav. Brain Res.170, 233–240 (2006).
   PubMed Web of Science ®Google Scholar
• Nilsson S, Makela S, Treuter E et al. Mechanisms of estrogen action. Physiol. Rev.81, 1535–1565 (2001).
   PubMed Web of Science ®Google Scholar
• D’Astous M, Mendez P, Morissette M, Garcia-Segura LM, Di Paolo T. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol. Pharmacol.69, 1492–1498 (2006).
   Google Scholar
• Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci.3, 433–442 (2002).
   PubMed Web of Science ®Google Scholar
• Kelly MJ, Qiu J, Ronnekleiv OK. Estrogen signaling in the hypothalamus. Vitam. Horm.71, 123–145 (2005).
   Google Scholar
• Woolley CS. Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol.47, 657–680 (2007).
   PubMed Web of Science ®Google Scholar
• Tanabe N, Kimoto T, Kawato S. Rapid Ca(2+) signaling induced by Bisphenol A in cultured rat hippocampal neurons. Neuro Endocrinol. Lett.27, 97–104 (2006).
   PubMed Web of Science ®Google Scholar
• Toran-Allerand CD. Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology145, 1069–1074 (2004).
   PubMed Web of Science ®Google Scholar
• Kelly MJ, Ronnekleiv OK, Ibrahim N, Lagrange AH, Wagner EJ. Estrogen modulation of K(+) channel activity in hypothalamic neurons involved in the control of the reproductive axis. Steroids67, 447–456 (2002).
   PubMedGoogle Scholar
• Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science307, 1625–1630 (2005).
   PubMed Web of Science ®Google Scholar
• Hewitt SC, Deroo BJ, Korach KS. Signal transduction. A new mediator for an old hormone? Science307, 1572–1573 (2005).
   Google Scholar
• Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun.346, 904–910 (2006).
   PubMed Web of Science ®Google Scholar
• Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol.20, 1996–2009 (2006).
   PubMed Web of Science ®Google Scholar
• Beyer C, Pawlak J, Karolczak M. Membrane receptors for oestrogen in the brain. J. Neurochem.87, 545–550 (2003).
   Google Scholar
• Scharfman HE, Maclusky NJ. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? Trends Neurosci.28, 79–85 (2005).
   PubMed Web of Science ®Google Scholar
• Scharfman HE, MacLusky NJ. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front. Neuroendocrinol.27, 415–413 (2006).
   PubMed Web of Science ®Google Scholar
• Berchtold NC, Kesslak JP, Pike CJ, Adlard PA, Cotman CW. Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus. Eur. J. Neurosci.14, 1992–2002 (2001).
   PubMed Web of Science ®Google Scholar
• Mendez P, Wandosell F, Garcia-Segura LM. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front. Neuroendocrinol.27, 391–403 (2006).
   PubMed Web of Science ®Google Scholar
• Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology138, 4030–4033 (1997).
   PubMedGoogle Scholar
• Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci.19, 1179–1188 (1999).
   PubMed Web of Science ®Google Scholar
• Singh M, Setalo G, Jr., Guan X, Frail DE, Toran-Allerand CD. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-α knock-out mice. J. Neurosci.20, 1694–1700 (2000).
   PubMedGoogle Scholar
• Bryant DN, Bosch MA, Ronnekleiv OK, Dorsa DM. 17-β estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience133, 343–352 (2005).
   PubMed Web of Science ®Google Scholar
• Bi R, Foy MR, Vouimba RM, Thompson RF, Baudry M. Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway. Proc. Natl Acad. Sci. USA98, 13391–13395 (2001).
   PubMed Web of Science ®Google Scholar
• Jover-Mengual T, Zukin RS, Etgen AM. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology148, 1131–1143 (2007).
   PubMedGoogle Scholar
• Nilsen J, Brinton RD. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc. Natl Acad. Sci. USA.100, 2842–2847 (2003).
   PubMed Web of Science ®Google Scholar
• Wise PM, Dubal DB, Rau SW, Brown CM, Suzuki S. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women’s health initiative. Endocr. Rev.26, 308–312 (2005).
   Google Scholar
• Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and β-catenin in the hippocampus. Mol. Cell. Neurosci.25, 363–373 (2004).
   PubMed Web of Science ®Google Scholar
• Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C. Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes. Neuroscience132, 581–589 (2005).
   PubMed Web of Science ®Google Scholar
• Alvarez-de-la-Rosa M, Silva I, Nilsen J et al. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer’s disease. Ann. NY Acad. Sci.1052, 210–224 (2005).
   Google Scholar
• Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA. Mitochondria play a central role in estrogen-induced neuroprotection. Curr. Drug Targets CNS Neurol. Disord.4, 69–83 (2005).
   PubMedGoogle Scholar
• Yang SH, Liu R, Perez EJ et al. Mitochondrial localization of estrogen receptor β. Proc. Natl Acad. Sci. USA101, 4130–4135 (2004).
   PubMed Web of Science ®Google Scholar
• Schwend T, Gustafsson JA. False positives in MALDI-TOF detection of ERβ in mitochondria. Biochem. Biophys. Res. Commun.343, 707–711 (2006).
   PubMed Web of Science ®Google Scholar
• Yang SH, Prokai L, Simpkins JW. Correspondence regarding Schwend and Gustafsson, “False positives in MALDI-TOF detection of ERβ in mitochondria”. Biochem. Biophys. Res. Commun.345, 917–918 (2006).
   Google Scholar
• Hsieh YC, Yu HP, Suzuki T et al. Upregulation of mitochondrial respiratory complex IV by estrogen receptor-β is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J. Mol. Cell. Cardiol.41, 511–521 (2006).
   PubMed Web of Science ®Google Scholar
• Dykens JA, Simpkins JW, Wang J, Gordon K. Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism. Exp. Gerontol.38, 101–107 (2003).
   PubMedGoogle Scholar
• Simpkins JW, Yang SH, Liu R et al. Estrogen-like compounds for ischemic neuroprotection. Stroke35(11 Suppl. 1), 2648–2651 (2004).
   PubMed Web of Science ®Google Scholar
• Blurton-Jones M, Tuszynski MH. Reactive astrocytes express estrogen receptors in the injured primate brain. J. Comp. Neurol.433, 115–123 (2001).
   PubMed Web of Science ®Google Scholar
• Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol.450, 256–271 (2002).
   PubMed Web of Science ®Google Scholar
• Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci.19, 6385–6393 (1999).
   PubMed Web of Science ®Google Scholar
• Sortino MA, Chisari M, Merlo S et al. Glia mediates the neuroprotective action of estradiol on β-amyloid-induced neuronal death. Endocrinology145, 5080–5086 (2004).
   PubMed Web of Science ®Google Scholar
• Dhandapani KM, Wade FM, Mahesh VB, Brann DW. Astrocyte-derived transforming growth factor-β mediates the neuroprotective effects of 17 β-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology146, 2749–2759 (2005).
   PubMedGoogle Scholar
• Garcia-Ovejero D, Azcoitia I, DonCarlos LL, Melcangi RC, Garcia-Segura LM. Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones. Brain Res. Brain Res. Rev.48, 273–286 (2005).
   PubMedGoogle Scholar
• Dodel RC, Du Y, Bales KR, Gao F, Paul SM. Sodium salicylate and 17β-estradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astroglial cultures following exposure to amyloid A β(1–40) and lipopolysaccharides. J. Neurochem.73, 1453–1460 (1999).
   PubMed Web of Science ®Google Scholar
• Vegeto E, Belcredito S, Etteri S et al. Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol. Proc. Natl Acad. Sci. USA.100, 9614–9619 (2003).
   PubMed Web of Science ®Google Scholar
• Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology147, 2263–2272 (2006).
   PubMed Web of Science ®Google Scholar
• Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol.111, 77–85 (2000).
   PubMed Web of Science ®Google Scholar
• Vegeto E, Bonincontro C, Pollio G et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci.21, 1809–1818 (2001).
   PubMed Web of Science ®Google Scholar
• Lavaque E, Sierra A, Azcoitia I, Garcia-Segura LM. Steroidogenic acute regulatory protein in the brain. Neuroscience138, 741–747 (2006).
   PubMedGoogle Scholar
• Papadopoulos V, Baraldi M, Guilarte TR et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci.27, 402–409 (2006).
   PubMed Web of Science ®Google Scholar
• Schumacher M, Akwa Y, Guennoun R et al. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol.29, 307–326 (2000).
   PubMedGoogle Scholar
• Lavaque E, Mayen A, Azcoitia I, Tena-Sempere M, Garcia-Segura LM. Sex differences, developmental changes, response to injury and cAMP regulation of the mRNA levels of steroidogenic acute regulatory protein, cytochrome p450scc, and aromatase in the olivocerebellar system. J. Neurobiol.66, 308–318 (2006).
   Google Scholar
• Veiga S, Azcoitia I, Garcia-Segura LM. Ro5–4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J. Neurosci. Res.80, 129–137 (2005).
   PubMed Web of Science ®Google Scholar
• Melcangi RC, Garcia-Segura LM. Therapeutic approaches to peripheral neuropathy based on neuroactive steroids. Expert Rev. Neurother.6, 1121–1125 (2006).
   PubMedGoogle Scholar
• Leonelli E, Yague JG, Ballabio M et al. Ro5–4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging-associated myelin degeneration in the sciatic nerve of male rats. Mech. Ageing Dev.126, 1159–1163 (2005).
   PubMed Web of Science ®Google Scholar
• Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int.40, 475–486 (2002).
   PubMed Web of Science ®Google Scholar
• Garcia-Segura LM, Veiga S, Sierra A, Melcangi RC, Azcoitia I. Aromatase: a neuroprotective enzyme. Prog. Neurobiol.71, 31–41 (2003).
   PubMedGoogle Scholar
• Zhou L, Lehan N, Wehrenberg U et al. Neuroprotection by estradiol: a role of aromatase against spine synapse loss after blockade of GABA(A) receptors. Exp. Neurol.203, 72–81 (2007).
   Google Scholar
• Yague JG, Munoz A, de Monasterio-Schrader P et al. Aromatase expression in the human temporal cortex. Neuroscience138, 389–401 (2006).
   Google Scholar
• Lund TD, Hinds LR, Handa RJ. The androgen 5α-dihydrotestosterone and its metabolite 5α-androstan-3β, 17β-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor β-expressing neurons in the hypothalamus. J. Neurosci.26, 1448–1456 (2006).
   PubMed Web of Science ®Google Scholar
• Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ. The androgen metabolite, 5α-androstane-3β, 17β-diol, is a potent modulator of estrogen receptor-β1-mediated gene transcription in neuronal cells. Endocrinology146, 147–155 (2005).
   PubMed Web of Science ®Google Scholar
• Soma KK, Sinchak K, Lakhter A, Schlinger BA, Micevych PE. Neurosteroids and female reproduction: estrogen increases 3β-HSD mRNA and activity in rat hypothalamus. Endocrinology146, 4386–4390 (2005).
   Google Scholar
• Toran-Allerand CD, Tinnikov AA, Singh RJ, Nethrapalli IS. 17α-estradiol: a brain-active estrogen? Endocrinology146, 3843–3850 (2005).
   PubMed Web of Science ®Google Scholar
• Simpkins JW, Wen Y, Perez E, Yang S, Wang X. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer’s disease neuropathology. Ann. NY Acad. Sci.1052, 233–242 (2005).
   Google Scholar
• Perez E, Liu R, Yang SH, Cai ZY, Covey DF, Simpkins JW. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res.1038, 216–222 (2005).
   Google Scholar
• Jung ME, Wilson AM, Simpkins JW. A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells. J. Pharmacol. Exp. Ther.319, 543–550 (2006).
   Google Scholar
• Wang X, Dykens JA, Perez E et al. Neuroprotective effects of 17β-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol.70, 395–404 (2006).
   PubMed Web of Science ®Google Scholar